Skip to main content

Selected References

Selected References

  • Chudasama, P., Konrad, A., Jochmann, R., Lausen, B., Holz, P., Naschberger, E., Neipel, F., Britzen-Laurent, N., Sturzl, M. (2015). Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis. Oncogene. 34, 639-649.
  • Behr, M., Kaufmann, J.K., Ketzer, P., Engelhardt, S., Muck-Hausl, M., Okun, P.M., Petersen, G., Neipel, F., Hassel, J.C., Ehrhardt, A., Enk, A.H., Nettelbeck, D.M. (2014). Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds. PLoS One. 9, e95723.
  • Hahn, A., Kaufmann, J.K., Wies, E., Naschberger, E., Panteleev-Ivlev, J., Schmidt, K., Holzer, A., Schmidt, M., Chen, J., König, S., Ensser, A., Myoung, J., Brockmeyer, N.H., Stürzl, M., Fleckenstein, B., Neipel, F. (2012). The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma-associated herpesvirus. Nat Med. 18: 961-966.
  • Schmidt, K., Wies, E., Neipel, F. (2011). Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits IFN-gamma and MHC-II expression. J Virol. 85: 4530-4537.
  • Hahn, A., Birkmann, A., Wies, E., Dorer, D., Mahr, K., Sturzl, M., Titgemeyer, F., Neipel, F. (2009). Kaposi's Sarcoma-Associated Herpes-virus gH/gL: Glycoprotein Export and Interaction with Cellular Receptors. J Virol. 83: 396-407.
  • Konrad, A., Wies, E., Thurau, M., Marquardt, G., Naschberger, E., Hentschel, S., Jochmann, R., Schulz, T.F., Erfle, H., Brors, B., Lausen, B., Neipel, F., Sturzl, M. (2009). A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J Virol. 83: 2563-2574.
  • Wies, E., Hahn, A.S., Schmidt, K., Viebahn, C., Rohland, N., Lux, A., Schellhorn, T., Holzer, A., Jung, J.U., Neipel, F. (2009). The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5. J Biol Chem. 284: 8525-8538.
  • Wies, E., Mori, Y., Hahn, A., Kremmer, E., Sturzl, M., Fleckenstein, B., Neipel, F. (2008). The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Blood. 111: 320-327.